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To be asked to reflect on one’s career is a true honor. A
career in science is a life-long journey. For me, this jour-
ney began quite early when I received a biology set as a
Christmas gift at the age of 8 years. This kit included
a microscope, tools for dissection, and a preserved frog.
As a teenager volunteering and then working at a local
hospital, my career interests drifted to providing care
for individuals and families with health problems,
and ultimately a career in health care. The practical
realities of college tuition and family expectations led
me to embark on an undergraduate education in nurs-
ing, but always with the thought that this would be the
first step in a life-long journey.
During my undergraduate program at Seattle
University, I was re-introduced to science through
courses in chemistry, microbiology and physiology.
However, the possibility of merging my professional
identity as a nurse with that of a scientist did not take
hold until I was a graduate student (Masters level) at
the University of Washington. There, I had the unique
opportunity to be mentored by two School of Nursing
faculty members (Drs Sue Donaldson and Barbara
Hansen) who held PhDs in physiology and biophysics.
Both had managed to take questions from their clinical
experiences as nurses and answer them in the labora-
tory. In turn, their laboratory findings helped to inform
the clinical care that they provided to patients and
their family members. This was the career model to
which I aspired. However, it was clear that additional
education and preparation were essential to make
this a reality.
WHY GASTROINTESTINAL (GI)
PROBLEMS?
Since the time of Captain William Beaumont, a United
States Army surgeon serving during the early to mid-
19th century, evidence has existed about the relation-
ship of stress to increases in gastric acid secretion. 
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He described the changes in the gastric mucosa of a
French trapper, Alexis St. Martin, in response to food
and liquids but also in the context of various emotions
(e.g. anger) [1]. Extending this work on the roles of
emotions and stress were physiologists Drs Walter
Cannon and Hans Selye, both pioneers in describing
the adverse effects of physical and psychological stress
and GI pathology [2,3]. It is important in science, as in
any field, to acknowledge the past and to read the
early works in one’s area of research.
For me, the link between the mind and the GI
tract was more personal. My mother and grandfather
had both been diagnosed with peptic ulcer disease
early in their adult lives. At that time, ulcers were
thought to be primarily associated with psychologi-
cal distress. The common belief was that simply
reducing your stress and eating bland foods would
decrease the probability of developing an ulcer. Thus
my desire to study GI function and stress was
directly linked to early experiences in helping my
mother as well as my patients understand that self-
management strategies, including diet and relax-
ation, could help reduce GI distress. It was still a
decade later before links between the bacterium
Helicobacter pylori, non-steroidal anti-inflammatory
drugs and ulcer formation would be established.
THE IMPORTANCE OF MENTORSHIP
Creating a balance between career and family life is
crucial for women and men in science. For me, the
pursuit of a doctoral degree necessitated relocating
1,700 miles from my family and more importantly,
my husband. Driving across the United States from
Seattle, Washington to Chicago, Illinois, it was diffi-
cult not to think of the family moments I would be
missing during the 4-year separation from family
and friends. The encouragement of my husband and
family were crucial to my ultimate success in obtain-
ing the PhD degree I needed to answer the questions
that I believed were important.
During my graduate program in physiology and
biophysics at the University of Illinois–Chicago, I 
encountered invaluable mentorship. My advisor Dr
Sabath Marotta was a well-established biomedical
researcher who focused on the physiological conse-
quences of stress. Under his guidance and support,
the original focus of my interest in GI function was
broadened to the examination of stress and its poten-
tial contribution to GI motility and activation of the
hypothalamic–pituitary–adrenal axis. Working with
a senior mentor passionate about bench research and
health science education provided me with a bal-
anced perspective on what my future academic life
would entail. The selection of a mentor with prior
experience in advancing the career of female scien-
tists (including those with backgrounds in nursing)
was also crucial. He taught me a number of skills
including scientific writing and experimental design.
More importantly, he led by example and demon-
strated creativity, accountability, and steadfastness in
tackling questions. His mentorship of me persisted
long after I had left his laboratory and only ended
with his death in 1996. He was the type of mentor
that I aspire to be.
The results of my dissertation work provided evi-
dence that experimentally induced stress (acute and
chronic) produces neurochemical changes in the devel-
oping male rat gut [4,5]. These findings would be the
launching pad for work that I would do both inde-
pendently and collaboratively. In addition, my grad-
uate students would build on these initial results.
COLLABORATION IS IMPORTANT FOR
SURVIVAL
Following completion of my PhD, I became an
Assistant Professor in the School of Nursing at the
University of Washington. At about the same time,
there was the creation of the National Center of Nurs-
ing Research at the National Institute of Health. This
institute facilitated and funded the research conducted
by doctorally prepared scientists engaged in health
research. Their funding priorities included health pro-
motion, self management, vulnerable populations, and
biomarker development. This agency has provided the
25 plus years of funding needed to conduct my research.
As I worked up the academic ranks, I became a
Professor in Nursing and an Adjunct Professor in the
Division of Gastroenterology in the School of Medicine
at the University of Washington. During the early years
of my academic career, I extended the basic research I
had started as a predoctoral graduate student. In par-
ticular, I delved further into the effects of stress, and
in particular, thyrotropin releasing hormone on GI
motility in a developing rat model. At the University
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of Washington, I found a new mentor in Dr Akira
Horita, a neuropharmacologist in the Department of
Pharmacology. Dr Horita provided expertise in the
design of studies focused on assessing the links, in
particular the neurochemical serotonin and its recep-
tors, between the brain and peripheral organ systems
such as the GI tract. He was among the first to observe
that the administration of thyrotropin releasing hor-
mone intracisternally resulted in rapid intestinal tran-
sit in rabbits [6]. Through work in his laboratory, 
I was able to develop additional skills to keep pace
with rapid advances in research technology.
Within the School of Nursing I was fortunate to
have colleagues including Drs Nancy Woods and
Joan Shaver and the facilities of the Center for
Women’s Health Research (funded by the National
Institute of Health). They consulted with me on the
clinical implications of my work related to stress. For
example, why were women more likely to experience
symptoms such as abdominal pain when stressed?
What is the physiological link between reproductive
hormones such as estrogen and progesterone and 
GI symptoms (pain, bloating and constipation) in
women? Together, we designed studies to examine
healthy women of menstruating age with and with-
out dysmenorrhea, and later, women with a specific
diagnosis of irritable bowel syndrome (IBS) [7]. At
about the same time, my colleague Dr Monica Jarrett,
a nurse with a PhD in psychology, and I began a col-
laboration that has lasted over 20 years as we have
worked to unravel the underpinnings of GI symptom
experiences of both men and women.
WHY STUDY IBS?
IBS is a common chronic functional bowel disorder
[8,9]. The impact of IBS has been measured in the sig-
nificant amount of health care resources used, for 
example, 8–10 doctor visits, 5 million prescriptions
per year [10,11]. Excess surgery is among the health
care events related to a diagnosis of IBS [12,13]. There
are numerous published reports about the negative
impact of IBS on quality of life, as well as work and
school performance [14,15]. IBS remains a symptom-
based diagnosis that affects primarily young to middle-
aged adult women [16]. IBS is characterized by a
constellation of GI symptoms outlined in the Rome
III criteria. These include abdominal pain relieved 
by bowel movement or associated with changes in
stool consistency for at least 3 days per month.
It has been suggested that IBS is a multi-component
disorder that is characterized by dysfunction in GI
motor activity, visceral sensation, inflammation/per-
meability, autonomic nervous system imbalance,
and/or the processing of internal and external infor-
mation by the central nervous system. Given the range
of bowel pattern characteristics and other symptoms, it
is not surprising that different etiologies may produce
a variety of reports of GI and extra-intestinal symp-
toms. The challenge in the treatment of IBS is identify-
ing subgroups of patients most likely to benefit from
promotility, gut-flora-targeted (e.g. probiotics), behav-
ioral, anti-anxiety and/or antinociceptive therapy.
WHY STUDY WOMEN WITH IBS?
In the US and other Western industrial countries, more
women than men seek health care services for IBS.
Studies from Asian countries provide equivocal evi-
dence for a gender difference in IBS, that is, some dem-
onstrate a female predominance [17,18] while others
do not [19,20]. Gender differences exist in types of GI
symptoms (e.g. women report greater problems with
constipation while men more frequently report diar-
rhea) as well as other extra-intestinal symptoms such as
poor sleep, fibromyalgia, and chronic fatigue. Dr Lin
Chang from University of California, Los Angeles
and I recently conducted a systematic review of the
published literature related to gender and IBS [21].
In studies with male and female rats, my colleague
Dr Eleanor Bond and I have described the effects of
estrogen and progesterone on basal motility and intes-
tinal transit, as well as in response to thyrotropin
releasing hormone [22]. We have established that the
presence of estrogen and progesterone influences ani-
mal gut motility response to stress. These findings have
informed us as we have considered the effects of the
menstrual cycle on bowel function and symptoms in
women with IBS. These findings have been dissemi-
nated in the published literature as well as through
national and international presentations [23–47].
Our studies have established that IBS symptoms
(1) are exacerbated at menses; (2) co-exist with other
functional somatic and visceral pain symptoms; (3)
are more severe/frequent in women with comorbid
anxiety and depression; (4) are exacerbated by acute
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stress; (5) are associated with higher levels of self-
reported chronic stress and reduced quality of life; (6)
vary by autonomic nervous system balance indica-
tors and symptom severity; (7) are linked to sleep
quality; and (8) are characterized by neuroendocrine
differences. Our current studies are focused on
explaining pain-related mechanisms involved in
women with IBS. The autonomic nervous system
provides the major linkage between the gut and the
brain and remains a continued focus of our work.
THE NEED FOR INTERDISCIPLINARY AND
TRANSLATIONAL RESEARCH
As this program of research has evolved over the
past 25 years, it has taken several twists and turns.
The types of questions that were asked have varied
because our findings, as well as others have continued
to point us in different directions. Often such explo-
rations mandated that we develop new collaborators
with expertise needed to answer the questions. Our
team grew to include psychiatrists, gastroenterolo-
gists, psychologists with expertise in behavioral ther-
apy, and pediatricians. These collaborations have
taken us from the bench to the clinic and back to the
bench. Based on earlier descriptive work, we have
designed and implemented two randomized clinical
trials of behavioral therapy for women with IBS
[36,47]. We tested a comprehensive intervention
including diet instruction and cognitive behavioral
therapy, delivered either in person or primarily via
the telephone, which reduced GI symptom distress
and enhanced quality of life in adults with IBS. At
this time, we are about to launch a clinical trial with 
a probiotic preparation to compare its effectiveness
relative to behavioral therapy.
The benchwork component of our studies has
moved from measures of stress hormones to collabo-
ration with a geneticist and measures of genetic poly-
morphisms involved in the regulation of serotonin
and catecholamines [40,46]. For example, specific
polymorphisms in the serotonin reuptake transporter
protein are associated with psychological distress in
IBS patients. Our current pursuit of a biomarker for
symptom vulnerability entails the use of mass spec-
troscopy and proteomics. The long range goal of this
work is to determine those individuals most susceptible
for development of chronic pain, as well as those
most likely to respond to behavioral management
approaches.
WOMEN AND SCIENCE CAREERS
In the early 1990s, the National Institute of Health
established the Office of Research in Women’s Health
to focus on enhancing health science in areas unique
to women. In addition, one important mission of this
institution is to develop opportunities and support
for recruitment, retention, re-entry, and advancement
of women in biomedical careers. In the United States,
women make up a growing percentage of students
who train to become biomedical scientists. Today, 
female scientists are as competitive as men in obtain-
ing research grants at all career stages. However,
trends illustrate that the career attrition of women is
disproportionate to that of their male counterparts. 
If these trends continue, we may experience a shortage
of biomedical scientists in the near future. The attrition
of women from scientific career paths represents a cru-
cial loss of intellectual capital for biomedical research.
The key to solving this problem is to identify what
are the challenges and barriers for women in science
careers. More importantly, it is imperative that we
understand the keys to success. First, it is clear that
women face many of the same work life challenges as
men, such as the balance of teaching with research,
competing for finite resources, disseminating findings
in peer-reviewed journals, and ultimately achieving
promotion and tenure. For many women, there are 
the additional challenges of balancing family life,
including care of children and parents. For many, the
characteristics of a successful scientific career include a
sense of personal satisfaction, intellectual stimulation,
avoidance of a sense of burnout, and well-deserved
recognition.
In my career, family priorities did overrule some
professional activities such as work-related travel
and outside engagements. Efforts were made to meld
the two when possible. For example, I would take my
two daughters and husband on business travel with
me whenever possible. As a visiting professor to
Chiang Mai University, Thailand, the entire family
accompanied me for the month-long stay. Living geo-
graphically close to my extended family also facili-
tated my career in innumerable ways from childcare
to social support.
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SUMMARY
When reading about the careers of many stellar female
scientists, I am reminded of how fortunate I have
been. My career has been facilitated by thoughtful and
creative individuals who readily embraced the impor-
tance of mentorship and collaboration. My work held
a strong personal interest for me. However, I would
be remiss in not acknowledging the long hours
studying as a student, the long days and nights in the
laboratory, the unavoidable time away from family, the
disappointments of proposals or papers not being
accepted, and at times, the frustration of dealing with
academic bureaucracy. With few exceptions, these have
been balanced by the satisfaction of finding answers,
sharing findings with colleagues and patients, the joy
of working with students, and training of the next
generation of scientists.
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